Your SlideShare is downloading. ×
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Endometrial Cancer Global Clinical Trials Review, H2, 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Endometrial Cancer Global Clinical Trials Review, H2, 2012

157

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
157
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Endometrial Cancer Global Clinical Trials Review, H2, 2012Report Details:Published:November 2012No. of Pages: 107Price: Single User License – US$2500Endometrial Cancer Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H2, 2012"provides data on the Endometrial Cancer clinical trial scenario. This report provides elementalinformation and data relating to the clinical trials on Endometrial Cancer. It includes an overview ofthe trial numbers and their recruitment status as per the site of trial conduction across the globe.The databook offers a preliminary coverage of disease clinical trials by their phase, trial status,prominence of the sponsors and also provides briefing pertaining to the number of trials for the keydrugs for treating Endometrial Cancer. This report is built using data and information sourced fromproprietary databases, primary and secondary research and in-house analysis by GlobalDatasteam of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more
  • 2. - Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210592-endometrial-cancer-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 5List of Figures 6Introduction 7Endometrial Cancer 7Report Guidance 7Clinical Trials by Region 8Clinical Trials by Country 9Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11Top Five Countries Contributing to Clinical Trials in Europe 12Top Countries Contributing to Clinical Trials in North America 13Top Countries Contributing to Clinical Trials in Middle East and Africa 14Top Countries Contributing to Clinical Trials in Central and South America 15Clinical Trials by BRIC Nations 16Clinical Trials by G7 Nations 17Clinical Trials in G7 Nations by Trial Status 18Clinical Trials by E7 Nations 19Clinical Trials in E7 Nations by Trial Status 20Clinical Trials by Phase 21In Progress Trials by Phase 22Clinical Trials by Trial Status 23Unaccomplished Trials of Endometrial Cancer 24Subjects Recruited Over a Period of Time 28Prominent Sponsors 29Top Companies Participating in Endometrial Cancer Therapeutics Clinical Trials 31Prominent Drug Comparison 33Clinical Trial Profiles 34Clinical Trial Overview of Top Companies 34Novartis AG 34Clinical Trial Overview of Novartis AG 34Sanofi 35Clinical Trial Overview of Sanofi 35GlaxoSmithKline plc 36Clinical Trial Overview of GlaxoSmithKline plc 36Eli Lilly and Company 37
  • 3. Clinical Trial Overview of Eli Lilly and Company 37Bristol-Myers Squibb Company 38Clinical Trial Overview of Bristol-Myers Squibb Company 38Merck & Co., Inc. 39Clinical Trial Overview of Merck & Co., Inc. 39Johnson & Johnson 40Clinical Trial Overview of Johnson & Johnson 40AEterna Zentaris Inc. 41Clinical Trial Overview of AEterna Zentaris Inc. 41Ipsen S.A. 42Clinical Trial Overview of Ipsen S.A. 42Precision Therapeutics, Inc. 43Clinical Trial Overview of Precision Therapeutics, Inc. 43Galena Biopharma, Inc. 44Clinical Trial Overview of Galena Biopharma, Inc. 44Ariad Pharmaceuticals, Inc. 45Clinical Trial Overview of Ariad Pharmaceuticals, Inc. 45EntreMed, Inc. 46Clinical Trial Overview of EntreMed, Inc. 46Novartis Pharmaceuticals Corporation 47Clinical Trial Overview of Novartis Pharmaceuticals Corporation 47MannKind Corporation 48Clinical Trial Overview of MannKind Corporation 48Pfizer Inc. 49Clinical Trial Overview of Pfizer Inc. 49Par Pharmaceutical Companies, Inc. 50Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 50Genentech, Inc. 51Clinical Trial Overview of Genentech, Inc. 51AstraZeneca PLC 52Clinical Trial Overview of AstraZeneca PLC 52Xoft Inc. 53Clinical Trial Overview of Xoft Inc. 53Clinical Trial Overview of Top Universities / Institutes / Hospitals 54The University of Texas M. D. Anderson Cancer Center 54Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 54Case Comprehensive Cancer Center 55Clinical Trial Overview of Case Comprehensive Cancer Center 55Memorial Sloan Kettering Cancer Center 56Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 56Dana-Farber Cancer Institute 57Clinical Trial Overview of Dana-Farber Cancer Institute 57
  • 4. National Taiwan University Hospital 58Clinical Trial Overview of National Taiwan University Hospital 58The University of New Mexico 59Clinical Trial Overview of The University of New Mexico 59Masonic Cancer Center 60Clinical Trial Overview of Masonic Cancer Center 60University of Wisconsin Madison 61Clinical Trial Overview of University of Wisconsin Madison 61University Health Network 62Clinical Trial Overview of University Health Network 62The Ohio State University 63Clinical Trial Overview of The Ohio State University 63New York University School of Medicine 64Clinical Trial Overview of New York University School of Medicine 64University of Virginia 65Clinical Trial Overview of University of Virginia 65Asan Medical Center 66Clinical Trial Overview of Asan Medical Center 66Osaka University 67Clinical Trial Overview of Osaka University 67Princess Margaret Hospital 68Clinical Trial Overview of Princess Margaret Hospital 68The Queensland Centre for Gynaecological Cancer 69Clinical Trial Overview of The Queensland Centre for Gynaecological Cancer 69University of Alabama at Birmingham 70Clinical Trial Overview of University of Alabama at Birmingham 70Rabin Medical Center 71Clinical Trial Overview of Rabin Medical Center 71USC Norris Comprehensive Cancer Center 72Clinical Trial Overview of USC Norris Comprehensive Cancer Center 72Leiden University Medical Center 73Clinical Trial Overview of Leiden University Medical Center 73Five Key Clinical Profiles 74Appendix 104Abbreviations 104Definitions 104Research Methodology 105Secondary Research 105About GlobalData 106Contact Us 106Disclaimer 106Source 107
  • 5. List of TablesEndometrial Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries,2012* 10Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 13Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries,2012* 15Endometrial Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16Endometrial Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17Endometrial Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18Endometrial Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19Endometrial Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Endometrial Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24Endometrial Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25Endometrial Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32Endometrial Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*33Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG,2012* 34Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 35Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKlineplc, 2012* 36Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly andCompany, 2012* 37Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-MyersSquibb Company, 2012* 38Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co.,Inc., 2012* 39Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson &Johnson, 2012* 40
  • 6. Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna ZentarisInc., 2012* 41Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A.,2012* 42Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrecisionTherapeutics, Inc., 2012* 43Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GalenaBiopharma, Inc., 2012* 44Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AriadPharmaceuticals, Inc., 2012* 45Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc.,2012* 46Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NovartisPharmaceuticals Corporation, 2012* 47Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKindCorporation, 2012* 48Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc.,2012* 49Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ParPharmaceutical Companies, Inc., 2012* 50Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc.,2012* 51Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZenecaPLC, 2012* 52Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Xoft Inc., 2012*53Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofTexas M. D. Anderson Cancer Center, 2012* 54Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CaseComprehensive Cancer Center, 2012* 55Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial SloanKettering Cancer Center, 2012* 56Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-FarberCancer Institute, 2012* 57Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National TaiwanUniversity Hospital, 2012* 58Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofNew Mexico, 2012* 59Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic CancerCenter, 2012* 60Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University ofWisconsin Madison, 2012* 61
  • 7. Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University HealthNetwork, 2012* 62Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio StateUniversity, 2012* 63Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New YorkUniversity School of Medicine, 2012* 64Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University ofVirginia, 2012* 65Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan MedicalCenter, 2012* 66Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OsakaUniversity, 2012* 67Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrincessMargaret Hospital, 2012* 68Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The QueenslandCentre for Gynaecological Cancer, 2012* 69Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University ofAlabama at Birmingham, 2012* 70Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin MedicalCenter, 2012* 71Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by USC NorrisComprehensive Cancer Center, 2012* 72Endometrial Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by LeidenUniversity Medical Center, 2012* 73List of FiguresEndometrial Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries,2012* 10Endometrial Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11Endometrial Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12Endometrial Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13Endometrial Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*14Endometrial Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%),2012* 15Endometrial Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16Endometrial Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17Endometrial Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18Endometrial Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19Endometrial Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
  • 8. Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21Endometrial Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22Endometrial Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23Endometrial Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28Endometrial Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29Endometrial Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31Endometrial Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*33GlobalData Methodology 105Contact: sales@reportsandreports.com for more information.

×